Terry Rich

Terry Rich

President and Chief Executive Officer

Terry Rich is President and Chief Executive Officer for the Company. Terry has a proven track record of leading global businesses, driving sales execution and building commercial organizations to drive growth. Prior to joining the Company, he led the turnaround of Alphatec Spine from December 2016 through December 2018. As a director and CEO, he strengthened the organization’s competencies, redirected the portfolio with 12 new products and laid the foundation for focused innovation and growth. Prior to Alphatec Spine, Terry was President of Upper Extremities at Wright Medical Group, N.V. Terry has held sales leadership positions at Tornier, NuVasive and DePuy Spine earlier in his career.

Kris Siemionow

Kris Siemionow

Chief Medical Officer

Dr. Kris Siemionow is Chief Medical Officer for the Company, as well as a surgeon, scientist, entrepreneur, and investor. He is a board-certified spine surgeon and Chief of Spine Surgery and Associate Tenured Professor of Orthopaedics and Neurosurgery at the University of Illinois in Chicago. Dr. Siemionow completed residency at the Cleveland Clinic Foundation in orthopedic surgery and a spine surgery fellowship at Rush University Medical Center. His Ph.D. focused on the effects of inflammation on nerve cell function. Dr. Siemionow is co-founder of Holosurgical, a digital surgery company focused on bringing cutting edge augmented reality and artificial intelligence to the surgical space, and Global Spine Outreach, a not-for-profit organization whose mission is to “save children with severe spinal deformities.” He co-founded Inteneural Networks Inc, a company that utilizes machine learning to diagnose neurodegenerative disorders. Dr. Siemionow also co-founded Kardiolytics Inc., a company that utilizes machine learning to perform a virtual coronary stress test. Dr. Siemionow has authored over 100 peer reviewed articles, abstracts, and book chapters pertaining to surgery and basic science research. He holds 25 patents and patent applications, which have been successfully commercialized.

Scott Durall

Scott Durall

Chief Commercial Officer

Scott Durall joined the company in June 2020 as Chief Commercial Officer, bringing 30 years of experience as a medical device sales and commercial leader. In his role he is responsible for U.S. sales, corporate accounts and commercial operations. Prior to joining Surgalign, Scott served as Executive Vice President of Sales with Earlens Corp. Previously, he spent 10 years at NuVasive, Inc. serving in numerous commercial leadership roles including EVP of Strategic Sales & Operations, VP of Commercial Strategy and Area VP of Sales. Scott began his medical device sales career at U.S. Surgical Corporation and served as Area Sales Director, before spending the next 10 years with Boston Scientific Corp. in roles including Director of Corporate Sales & National Accounts. Scott received a Bachelor of Business Administration in Marketing from the University of Kentucky.

John Rotella

John Rotella

Chief of Staff

John Rotella is Chief of Staff for the Company reporting to Terry Rich. He brings more than 20 years of experience in the medical device industry, including driving positive workplace culture and leading successful teams. His background in product development and manufacturing focuses on understanding physicians’ needs and improving patients’ lives. John started his career in R&D at Kimberly-Clark Healthcare/Halyard Health, holding 32 U.S. patents in digestive health, acute pain and surgical, infection and prevention healthcare devices. He later held a position as a plant manager for Avanos Medical in Tijuana, MX where he supported HPMS implementation. Prior to joining Surgalign, he served as Senior Director of Operations for Owens & Minor Halyard.

John earned a Master of Science degree in Biomedical Engineering and a Bachelor of Science degree in Materials Science & Engineering from the University of Florida. 

Bob Watkins

Bob Watkins

Chief Technology Officer

Bob Watkins is Chief Technology Officer for the Company. He brings more than 25 years of global experience in a range of industries including medical devices, electronics, materials, engineering and manufacturing. Bob has a broad business perspective that is a result of leading multiple functions, including information technology, supply chain, product marketing, and engineering. He is passionate about leveraging technology and change leadership to drive business transformation, and has successfully led multiple digital, supply chain, and technology transformations. In his role, Bob focuses on three specific areas for Surgalign: IT strategy & execution, business process development, and the implementation and commercialization of our digital strategy. Prior to joining Surgalign, Bob was Vice President of IT for R&D, Supply Chain, Quality and Regulatory at Smith & Nephew. Previously he held leadership roles at Johnson Controls, General Electric and SABIC. He holds a Bachelor of Science degree in chemical engineering from the University of Massachusetts. 

Doug Bireley

Doug Bireley

Executive Vice President, Marketing and R&D

Douglas S. Bireley joined the company in August 2020 as Executive Vice President, Marketing and Research & Development with over 20 years of Spine experience in marketing and product development and a strong record of accomplishment in brand strategy, technology innovation and business development. Prior to joining Surgalign, Doug was Senior Director of Global Strategic Marketing for Robotics & Digital Surgery at Johnson & Johnson. He spent more than 20 years at Johnson & Johnson in various marketing and R&D roles of increasing responsibility, including leading the commercial integration of DePuy Spine and Synthes Spine. He also has significant international experience including time spent living overseas. Doug holds a Bachelor of Science degree in business administration from Bucknell University.

Bryan Cornwall

Bryan Cornwall

Executive Vice President, Research and Clinical Affairs

G. Bryan Cornwall, PhD, MBA, PEng joined the Company in June 2020 as Executive Vice President, Research and Clinical Affairs. Bryan brings his 25 years of clinical operations and research experience in the medical device industry from the University of San Diego’s Shiley-Marcos School of Engineering, where he was an Associate Professor of Mechanical Engineering. His experience driving innovation through scientific competence within the spine industry, combined with his strong surgeon relationships, will aid the continued development of Surgalign’s global spine portfolio with a focus on clinical differentiation. He is well-published with more than 24 peer-reviewed publications, 24 U.S. patents and eight book chapters. Bryan previously held leadership roles in his 12-plus-year tenure at NuVasive, including President SOLAS & NSF, Senior Vice President of Clinical Operations & Research, Senior Vice President of Research & Clinical Resources, and Vice President of R&D, as well as leadership roles at MacroPore Biosurgery and DePuy-ACE.

Enrico Sangiorgio

Enrico Sangiorgio

Executive Vice President, International

Enrico Sangiorgio was named Vice President and General Manager, International in June 2017. Enrico brings 20-plus years of diverse commercial and leadership experience building effective teams and driving international expansion. His expertise includes experience in sales, marketing, business development, general management, and mergers and acquisitions in multiple geographies covering medical devices, pharma, biotech, consumer health and digital health solutions. Prior to joining the Company, Enrico led new business development for women’s health and urology in the Europe, Middle East and Africa (EMEA) region at BARD Medical, in continuation of his work as head of distributor markets EMEA at American Medical Systems (AMS)/Boston Scientific. Prior to AMS, he was Vice President of Business Development at Evofem BioSciences covering international markets. Earlier in his carrier, he was Vice President of Global Sales and Marketing at WCG, European brand leader at Astellas Pharma and marketing lead at Merck and Co. Enrico earned a Master of Science in development economics from the SOAS University of London and a Bachelor of Science in business administration from the LUISS Business School in Rome.

Josh DeRienzis

Josh DeRienzis

Chief Legal Officer and Corporate Secretary

Josh DeRienzis is Chief Legal Officer and Corporate Secretary, and leads the Company’s global Legal, IP and Compliance teams. He brings more than 20 years of experience advising senior management and Boards of Directors on critical legal and strategic matters, with a focus on securities, finance, mergers and acquisitions, commercial transactions, governance and litigation. He was most recently Vice President, Assistant General Counsel, Corporate Secretary and Chief Compliance Officer at The Williams Companies, Inc., a Fortune 500 midstream energy company. Prior to that role, Josh was the General Counsel and Corporate Secretary of PSS World Medical, Inc., a publicly-traded medical supplies distributor to the primary and elder care markets, where he also managed the compliance function. After PSS was acquired by McKesson Corp. in 2013, he remained as the chief legal officer for McKesson’s specialty health division for several years. Prior to PSS, Josh held roles of increasing responsibility at other large publicly traded companies and worked at two major New York law firms. He earned a bachelor’s degree from the State University of New York at Albany and a Juris Doctor from the Benjamin N. Cardozo School of Law.

Marc Mackey

Marc Mackey

Executive Vice President, Digital Surgery

Marc Mackey is Executive Vice President of Digital Surgery for the Company. He leads the company’s efforts to deliver on the promise of digital surgery. Marc has more than 25 years of orthopedic and surgical-enabling technology experience across the spectrum of business functions, including product development and strategic marketing, business development, corporate strategy, technology innovation, and post-acquisition portfolio integration. He spent more than 20 years at Brainlab, leading the orthopedic division prior to its acquisition by Smith+Nephew in 2019. When that acquisition closed, Marc led the integration and assumed leadership of the digital surgery and robotics division. He began his career as a life sciences research engineer in the space shuttle program and started his medical device career in sales of neurosurgical robotics. Marc holds a Bachelor’s degree in Aeronautical and Astronautical Engineering from Purdue University and a Master’s in Bioengineering from the University of California, San Diego.